Correlation Ventures focuses on co-investing across all industry sectors and investment stages, from pre-seed to growth, with a notable activity in Technology and Healthcare. Their strategy leverages a proprietary, data-driven predictive model to make rapid investment decisions, typically within days, without taking board seats.
Portfolio
13
Fund Size
$500M
Top Stage
Seed
Last 12 Mo
2
Team
Stage Distribution
Portfolio
13 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| dub | Series A | $30M | May 2025 |
| Nervonik | Series A | $13M | Mar 2025 |
| Candesant Biomedical | Series B | $35M | Jun 2023 |
| Wrangle | Seed | $2M | May 2023 |
| Angle Health | Series A | $58M | Jan 2023 |
| Onward | Series A | $9.7M | Oct 2022 |
| Bubble | Pre-Seed | $1.8M | Jan 2022 |
| HelloHero | Seed | $7.7M | Dec 2021 |
| Applied XL | Seed | $1.5M | Apr 2021 |
| Lemonaid Health | Series B | $33M | Jul 2020 |
| Zippia | Series A | $8.5M | Apr 2019 |
| Swivel | Seed | $4.8M | Jul 2018 |
| Kaiyo | Seed | $5M | — |
Top Co-Investors
Tuesday Capital2 shared
Lerer Hippeau2 shared
Silverton Partners1 shared
Portage Ventures1 shared
Wing1 shared
SixThirty Ventures1 shared
Mindset Venture1 shared
Crew Capital1 shared
Blumberg Capital1 shared
TSVC1 shared
Y Combinator1 shared
Accomplice1 shared
Bloomberg Beta1 shared
Eniac Ventures1 shared
First Round Capital1 shared
Fuel Ventures1 shared
Great Oaks1 shared
Hack VC1 shared
Factory1 shared
Abstract Ventures1 shared
Last updated: 1 March 2026